TellWell
← Back to feed
Science6h ago85% confidenceConfidence 85% — the share of independent, credible sources corroborating the core facts.

New Fusion Promoters Show Promise for Retinal Gene Therapy

1 source

Researchers developed two synthetic fusion promoters called Pikali and Nocchu that enable more efficient and balanced gene expression in both rod and cone photoreceptors compared to existing promoters. The new promoters combine elements from cone-specific and rod-specific promoters to achieve broader cellular coverage and higher expression levels in human retinal tissue models. This advancement could improve gene therapy treatments for inherited retinal diseases by overcoming current limitations in targeting photoreceptors.

Scientists created two fusion promoters, Pikali and Nocchu, by combining PR1.7 (a cone-specific promoter) with GRK1 (a rod-active promoter) to address a major challenge in retinal gene therapy: achieving efficient and balanced transgene expression across both photoreceptor types. Testing in human iPSC-derived retinal organoids showed that both fusion constructs outperformed their individual parental promoters, achieving transduction in 30-45% of photoreceptors with higher expression levels than GRK1 alone and broader cellular coverage than PR1.7 alone. The researchers propose these fusion constructs as candidates for next-generation gene therapy vectors targeting inherited retinal dystrophies. By combining the specificity of cone-targeting with the efficiency of rod-targeting, the approach represents a novel strategy that could advance clinical translation of retinal gene therapies.

Limitations & open questions

The article does not specify the timeline for clinical trials or discuss potential safety concerns and off-target effects that would need to be addressed before human testing. Additionally, it lacks information about how these promoters compare to other emerging fusion promoter strategies in the field.

What different sources said

  • bioRxivCenter

    Promfusion: a synthetic fusion promoter enabling enhanced and balanced photoreceptor transgene expression

Related

ScienceConfidence 88% — the share of independent, credible sources corroborating the core facts.

New AI Framework Improves Evidence-Based Analysis for Muon Collider Research

Researchers have developed an AI system called agentic hybrid RAG that combines retrieval and reasoning techniques to help scientists find and verify evidence in muon collider research literature. The framework integrates both keyword-based and semantic search methods with AI reasoning to decompose complex queries and synthesize answers. This work addresses a growing need in high-energy physics for AI-assisted tools that can reliably navigate rapidly expanding scientific literature.

1 source13m ago
ScienceConfidence 85% — the share of independent, credible sources corroborating the core facts.

NASA Announces Four-Astronaut Crew for Artemis III Moon Mission

NASA named three U.S. astronauts and one Italian astronaut from the European Space Agency as the crew for Artemis III, scheduled to launch in 2027. The mission will conduct a docking demonstration in Earth's orbit and test moon landers from SpaceX and Blue Origin. The crew includes a veteran test pilot, a record-holder for longest U.S. spaceflight, and a first-time space flyer.

1 source13m ago
ScienceConfidence 88% — the share of independent, credible sources corroborating the core facts.

Rare Great White shark filmed in Mediterranean Sea between Tunisia and Sicily

A volunteer diver captured rare footage of a Great White shark in the Mediterranean Sea in May while working to document ghost fishing nets. The sighting is significant because Great Whites are thought to be near extinction in the Mediterranean due to overfishing. Conservationists hope the discovery will prompt governments to establish marine protected areas in the region.

1 source13m ago